149 related articles for article (PubMed ID: 35928223)
1. A B7-CD28 Family-Based Signature Demonstrates Significantly Different Prognosis and Immunological Characteristics in Diffuse Gliomas.
Deng X; Chen K; Ren J; Zeng J; Zhang Q; Li T; Tang Q; Zhu J
Front Mol Biosci; 2022; 9():849723. PubMed ID: 35928223
[TBL] [Abstract][Full Text] [Related]
2. A B7-CD28 family based signature demonstrates significantly different prognoses and tumor immune landscapes in lung adenocarcinoma.
Zheng S; Luo X; Dong C; Zheng D; Xie J; Zhuge L; Sun Y; Chen H
Int J Cancer; 2018 Nov; 143(10):2592-2601. PubMed ID: 30152019
[TBL] [Abstract][Full Text] [Related]
3. An immune checkpoint-based signature predicts prognosis and chemotherapy response for patients with small cell lung cancer.
Wang L; Wu P; Shen Z; Yu Q; Zhang Y; Ye F; Chen K; Zhao J
Int Immunopharmacol; 2023 Apr; 117():109827. PubMed ID: 36989973
[TBL] [Abstract][Full Text] [Related]
4. Genetic and clinical characterization of B7-H3 (CD276) expression and epigenetic regulation in diffuse brain glioma.
Wang Z; Wang Z; Zhang C; Liu X; Li G; Liu S; Sun L; Liang J; Hu H; Liu Y; Zhang W; Jiang T
Cancer Sci; 2018 Sep; 109(9):2697-2705. PubMed ID: 30027617
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive analysis of a TNF family based-signature in diffuse gliomas with regard to prognosis and immune significance.
Wang QW; Lin WW; Zhu YJ
Cell Commun Signal; 2022 Jan; 20(1):6. PubMed ID: 35000592
[TBL] [Abstract][Full Text] [Related]
6. Identification of Iron Metabolism-Related Genes as Prognostic Indicators for Lower-Grade Glioma.
Xu S; Wang Z; Ye J; Mei S; Zhang J
Front Oncol; 2021; 11():729103. PubMed ID: 34568059
[TBL] [Abstract][Full Text] [Related]
7. B7-CD28 gene family expression is associated with prognostic and immunological characteristics of diffuse large B-cell lymphoma.
Wang G; Fu X; Chang Y; Li X; Wu X; Li L; Zhang L; Sun Z; Zhang X; Zhang M
Aging (Albany NY); 2019 Jun; 11(12):3939-3957. PubMed ID: 31195368
[TBL] [Abstract][Full Text] [Related]
8. A nuclear transport-related gene signature combined with IDH mutation and 1p/19q codeletion better predicts the prognosis of glioma patients.
Zhu Z; Lan Y; Wang L; Ge J; Wang J; Liu F; He Z; Zhang H; Luo M; Lin D; Tan Y; Xu Y; Luo T
BMC Cancer; 2020 Nov; 20(1):1072. PubMed ID: 33167941
[TBL] [Abstract][Full Text] [Related]
9. Pyroptosis-Related Gene Signature Predicts Prognosis and Indicates Immune Microenvironment Infiltration in Glioma.
Zhang Y; Zhang C; Yang Y; Wang G; Wang Z; Liu J; Zhang L; Yu Y
Front Cell Dev Biol; 2022; 10():862493. PubMed ID: 35547808
[No Abstract] [Full Text] [Related]
10. Glutamine metabolism-related genes predict prognosis and reshape tumor microenvironment immune characteristics in diffuse gliomas.
Fan H; Zhang S; Yuan Y; Chen S; Li W; Wang Z; Xiang Y; Li J; Ma X; Liu Y
Front Neurol; 2023; 14():1104738. PubMed ID: 36970537
[TBL] [Abstract][Full Text] [Related]
11. A Prognostic DNA Damage Repair Genes Signature and Its Impact on Immune Cell Infiltration in Glioma.
Wang G; Zhou H; Tian L; Yan T; Han X; Chen P; Li H; Wang W; Xiao Z; Hou L; Xue X
Front Oncol; 2021; 11():682932. PubMed ID: 34123852
[TBL] [Abstract][Full Text] [Related]
12. A Prognostic Microenvironment-Related Immune Signature
Qiu H; Li Y; Cheng S; Li J; He C; Li J
Front Oncol; 2020; 10():580263. PubMed ID: 33425732
[TBL] [Abstract][Full Text] [Related]
13. A Novel Signature Constructed by RNA-Binding Protein Coding Genes to Improve Overall Survival Prediction of Glioma Patients.
Tu Z; Shu L; Li J; Wu L; Tao C; Ye M; Zhu X; Huang K
Front Cell Dev Biol; 2020; 8():588368. PubMed ID: 33634092
[TBL] [Abstract][Full Text] [Related]
14. An Autophagy-Related Gene Signature Associated With Clinical Prognosis and Immune Microenvironment in Gliomas.
Xu Y; Li R; Li X; Dong N; Wu D; Hou L; Yin K; Zhao C
Front Oncol; 2020; 10():571189. PubMed ID: 33194668
[TBL] [Abstract][Full Text] [Related]
15. Large-scale analysis reveals the specific clinical and immune features of B7-H3 in glioma.
Zhang C; Zhang Z; Li F; Shen Z; Qiao Y; Li L; Liu S; Song M; Zhao X; Ren F; He Q; Yang B; Fan R; Zhang Y
Oncoimmunology; 2018; 7(11):e1461304. PubMed ID: 30377558
[No Abstract] [Full Text] [Related]
16. Comprehensive Characterization of a Novel E3-Related Gene Signature With Implications in Prognosis and Immunotherapy of Low-Grade Gliomas.
Tan S; Spear R; Zhao J; Sun X; Wang P
Front Genet; 2022; 13():905047. PubMed ID: 35832194
[TBL] [Abstract][Full Text] [Related]
17. Novel Immune-Related Gene Signature for Risk Stratification and Prognosis of Survival in Lower-Grade Glioma.
Zhang M; Wang X; Chen X; Zhang Q; Hong J
Front Genet; 2020; 11():363. PubMed ID: 32351547
[TBL] [Abstract][Full Text] [Related]
18. The combination of novel immune checkpoints HHLA2 and ICOSLG: A new system to predict survival and immune features in esophageal squamous cell carcinoma.
Zhang C; Wang F; Sun N; Zhang Z; Zhang G; Zhang Z; Luo Y; Che Y; Cheng H; Li J; He J
Genes Dis; 2022 Mar; 9(2):415-428. PubMed ID: 35224157
[TBL] [Abstract][Full Text] [Related]
19. Systematic identification, development, and validation of prognostic biomarkers involving the tumor-immune microenvironment for glioblastoma.
Zhao B; Wang Y; Wang Y; Chen W; Liu PH; Kong Z; Dai C; Wang Y; Ma W
J Cell Physiol; 2021 Jan; 236(1):507-522. PubMed ID: 32572951
[TBL] [Abstract][Full Text] [Related]
20. Bioinformatic Profiling Identifies a Fatty Acid Metabolism-Related Gene Risk Signature for Malignancy, Prognosis, and Immune Phenotype of Glioma.
Qi Y; Chen D; Lu Q; Yao Y; Ji C
Dis Markers; 2019; 2019():3917040. PubMed ID: 31885736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
